Time- and dose-dependent effects of corticotropin releasing factor on cerebral glucose metabolism in rats

被引:0
作者
U. Freo
C. Ori
S. R. B. Weiss
G. I. Perini
机构
[1] University of Padova,Department of Neurosciences
[2] University of Padova,Department of Pharmacology and Anesthesiology
来源
Journal of Neural Transmission | 2005年 / 112卷
关键词
Keywords: Corticotropin releasing factor, cerebral glucose metabolism, deoxyglucose, rat, locus coeruleus.;
D O I
暂无
中图分类号
学科分类号
摘要
The time course and the relation to dose of locomotor activity and of the regional cerebral metabolic rates for glucose (rCMRglc) were measured in freely moving Sprague-Dawley rats after intracerebroventricular administration of ovine corticotropin releasing factor (oCRF). Motor activity was determined using a familiar photocage cell. rCMRglc was measured, using the quantitative autoradiographic [14C]2-deoxyglucose procedure, in 73 brain regions at 10, 30, 90 and 180 min after administration of oCRF 10 µg and at 90 min after oCRF 0.1, 1 and 100 µg. oCRF 10 µg increased motor activity in a sustained fashion and increased rCMRglc with different time courses throughout brain regions. In cerebellar regions rCMRglc increases peaked at 90 min and were sustained up to 180 min. In non-cerebellar regions rCMRglc increases peaked at 90 min but declined thereafter. At lower doses (0.1 and 1 µg) oCRF increased rCMRglc in fewer brain regions (1 and 5 regions affected, average increases 1% and 7%) including cerebellar areas and brainstem sensory nuclei and decreased rCMRglc in medial prefrontal cortex. At the highest dose (100 µg) oCRF induced large and widespread rCMRglc increases in cerebellar, brainstem, hypothalamic, limbic and neocortical areas (40 brain regions affected, average increase 32%). The findings indicate that cerebellar areas and brainstem nuclei are highly sensitive to oCRF and may mediate oCRF autonomic and behavioral effects.
引用
收藏
页码:1447 / 1462
页数:15
相关论文
共 245 条
[1]  
Ardati A(1999)Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacology 38 441-448
[2]  
Goetschy V(1995)CRH and the noradrenergic system mediate the antinociceptive effect of central interleukin-1 alpha in the rat. Brain Res Bull 35 113-117
[3]  
Gottowick J(1992)Differential modulation of Purkinje cell activity by enkephalin and corticotropin releasing factor. Neuropeptides 22 167-174
[4]  
Henriot S(1994)Characterization of opioid receptor types and subtypes with new ligands. Ann NY Acad Sci 757 339-352
[5]  
Valdenaire O(1990)Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion in the locus coeruleus. J Neurosci 10 176-183
[6]  
Deuschle U(1986)Alterations in corticotropin-releasing factor-like immunoreactivity in discrete brain regions after acute and chronic stress. J Neurosci 6 2908-2914
[7]  
Kilpatrick GJ(1992)Noradrenergic mediation of the memory enhancing effect of corticotropin relasing factor in the locus coeruleus of rats. Psychoneuroendocrinology 17 113-124
[8]  
Bianchi M(1994)Corticotropin-releasing factor neurotransmission in the locus coeruleus: a possible site of antidepressant action. Brain Res Bull 35 581-587
[9]  
Panerai AE(1998)Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release. J Neurochem 71 622-629
[10]  
Bishop GA(1986)Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in the cerebral cortex of Alzheimer’s disease. Nature 319 593-595